NCT03842631

Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination

Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination: a Single Center, Open Cohort Study.

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 150 (estimated)
• Sponsor: XiaoXi Lin · Academic / Other
• Sex: All
• Age: 6 Months
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the safety and efficacy of Timolol Maleate treatment for different depth of infantile hemangioma based on B-ultrasonography. Based on the depth of hemangioma, patients will be proactively allocated to two groups. And then, all patients in both groups will receive topical timolol treatment in the same protocol and dosage.

Detailed description

Primary: Describe the efficacy of 0.5% topical timolol maleate drops in different depth of infantile hemangioma as assessed through IB-ultrasound.

Conditions

• Infantile Hemangioma

Interventions

Type	Name	Description
DRUG	Timolol Maleate 0.5% Oph Soln	External use of 0.5% Timolol Maleate Drops for all patients in different depths of IH lesion.

Timeline

• Start date: 2019-02-16
• Primary completion: 2020-06-01
• Completion: 2020-12-01
• First posted: 2019-02-15
• Last updated: 2019-02-19

Locations

1 site across 1 country: China